Rayala Swetha

510 total citations
18 papers, 405 citations indexed

About

Rayala Swetha is a scholar working on Computational Theory and Mathematics, Pharmacology and Molecular Biology. According to data from OpenAlex, Rayala Swetha has authored 18 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Computational Theory and Mathematics, 7 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Rayala Swetha's work include Computational Drug Discovery Methods (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Alzheimer's disease research and treatments (5 papers). Rayala Swetha is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Alzheimer's disease research and treatments (5 papers). Rayala Swetha collaborates with scholars based in India, United States and China. Rayala Swetha's co-authors include Sushil Kumar Singh, Gopichand Gutti, Ashok Kumar, N. Selvamurugan, Ankit Ganeshpurkar, Vishal Mohanakrishnan, Arumugam Balasubramanian, Devendra Kumar, Binod K. Bharati and Meenakshi Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and International Journal of Biological Macromolecules.

In The Last Decade

Rayala Swetha

17 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rayala Swetha India 12 201 86 83 74 70 18 405
Madhu Sudhana Saddala United States 15 191 1.0× 30 0.3× 47 0.6× 39 0.5× 18 0.3× 42 515
Jacek Kabziński Poland 12 217 1.1× 67 0.8× 54 0.7× 69 0.9× 14 0.2× 26 351
Liyan Qu China 8 253 1.3× 126 1.5× 16 0.2× 103 1.4× 62 0.9× 14 584
Yongli Du China 14 247 1.2× 29 0.3× 16 0.2× 38 0.5× 47 0.7× 29 394
Junjie Lan China 12 175 0.9× 75 0.9× 15 0.2× 48 0.6× 20 0.3× 25 389
Jessica M. Strasser United States 10 410 2.0× 50 0.6× 142 1.7× 11 0.1× 22 0.3× 15 560
Joana B. Loureiro Portugal 12 237 1.2× 27 0.3× 21 0.3× 46 0.6× 16 0.2× 20 413
Su-Chan Lee South Korea 13 202 1.0× 89 1.0× 19 0.2× 43 0.6× 19 0.3× 23 407
Tzu-Ying Chiang Taiwan 6 268 1.3× 67 0.8× 12 0.1× 18 0.2× 55 0.8× 8 452
Jean Eastman United States 7 217 1.1× 92 1.1× 65 0.8× 26 0.4× 34 0.5× 9 383

Countries citing papers authored by Rayala Swetha

Since Specialization
Citations

This map shows the geographic impact of Rayala Swetha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rayala Swetha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rayala Swetha more than expected).

Fields of papers citing papers by Rayala Swetha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rayala Swetha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rayala Swetha. The network helps show where Rayala Swetha may publish in the future.

Co-authorship network of co-authors of Rayala Swetha

This figure shows the co-authorship network connecting the top 25 collaborators of Rayala Swetha. A scholar is included among the top collaborators of Rayala Swetha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rayala Swetha. Rayala Swetha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Ganeshpurkar, Ankit, et al.. (2022). Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach. International Journal of Biological Macromolecules. 203. 195–211. 13 indexed citations
3.
Swetha, Rayala, A. Sharma, Ankit Ganeshpurkar, et al.. (2022). Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer’s disease. Molecular Diversity. 26(5). 2877–2892. 7 indexed citations
4.
Swetha, Rayala, et al.. (2022). Combined structure and ligand-based design of dual BACE-1/GSK-3β inhibitors for Alzheimer’s disease. Chemical Papers. 76(12). 7507–7524. 5 indexed citations
5.
Ganeshpurkar, Ankit, et al.. (2022). Identification of potential death-associated protein kinase-1 (DAPK1) inhibitors by an integrated ligand-based and structure-based computational drug design approach. Journal of Biomolecular Structure and Dynamics. 41(20). 10785–10797. 11 indexed citations
6.
Singh, Sushil Kumar, et al.. (2022). Cathepsin B-A Neuronal Death Mediator in Alzheimer’s Disease Leading to Neurodegeneration. Mini-Reviews in Medicinal Chemistry. 22(15). 2012–2023. 11 indexed citations
7.
Ganeshpurkar, Ankit, et al.. (2022). Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors. Journal of Biomolecular Structure and Dynamics. 41(13). 6089–6103. 7 indexed citations
8.
Swetha, Rayala, et al.. (2021). A Systematic Review of carbohydrate-based Bioactive Molecules for Alzheimer’s Disease. Future Medicinal Chemistry. 13(19). 1695–1711. 11 indexed citations
9.
Swetha, Rayala, Gopichand Gutti, Anjali Sharma, et al.. (2021). Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2. SHILAP Revista de lepidopterología. 2. 100026–100026. 26 indexed citations
10.
Swetha, Rayala, et al.. (2019). Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer. Bioorganic Chemistry. 94. 103380–103380. 23 indexed citations
11.
Ganeshpurkar, Ankit, Rayala Swetha, Devendra Kumar, et al.. (2019). Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease. Current Topics in Medicinal Chemistry. 19(7). 501–533. 25 indexed citations
12.
Swetha, Rayala, et al.. (2019). Estrogen signaling: An emanating therapeutic target for breast cancer treatment. European Journal of Medicinal Chemistry. 177. 116–143. 98 indexed citations
13.
Swetha, Rayala, Devendra Kumar, Sukesh Kumar Gupta, et al.. (2019). Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease. Future Medicinal Chemistry. 11(24). 3161–3178. 35 indexed citations
14.
Swetha, Rayala, et al.. (2018). Biomolecular Basis of Matrix Metallo Proteinase-9 Activity. Future Medicinal Chemistry. 10(9). 1093–1112. 23 indexed citations
15.
Mohanakrishnan, Vishal, et al.. (2017). Role of Runx2 in breast cancer-mediated bone metastasis. International Journal of Biological Macromolecules. 99. 608–614. 54 indexed citations
16.
Swetha, Rayala, et al.. (2016). Transforming growth factor-β1 regulation of ATF-3, c-Jun and JunB proteins for activation of matrix metalloproteinase-13 gene in human breast cancer cells. International Journal of Biological Macromolecules. 94(Pt A). 370–377. 37 indexed citations
17.
Swetha, Rayala, et al.. (2014). FORMULATION AND EVALUATION OF CELECOXIB BIOADHESIVE MICROSPHERES. 1 indexed citations
18.
Bharati, Binod K., Rayala Swetha, & Dipankar Chatterji. (2013). Identification and characterization of starvation induced msdgc-1 promoter involved in the c-di-GMP turnover. Gene. 528(2). 99–108. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026